SCHEMBL7138299

SCHEMBL7138299

CCCc1n[nH]c2ccc(Oc3c(C)cc(N)cc3C)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 4/20 0.38
THRB P10828 4/20 0.38
TTK P33981 5/20 0.36
LRRK2 Q5S007 1/20 0.34
MAPK8 P45983 3/20 0.33
GRM4 Q14833 1/20 0.32
JAK2 O60674 2/20 0.31
AXL P30530 1/20 0.31
ENPP3 O14638 1/20 0.31
ALPL P05186 1/20 0.31
ENPP1 P22413 1/20 0.31
XIAP P98170 1/20 0.31
GSK3B P49841 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130591 0.92 THRA (0.44) THRATHRBTTKLRRK2MAPK8
SCHEMBL7131426 0.84 GSK3B (0.37) THRATHRBTTKLRRK2GRM4
SCHEMBL7141223 0.83 CNR2 (0.41) THRATHRBTTKLRRK2MEN1
SCHEMBL7138045 0.80 THRA (0.48) THRATHRBTTKLRRK2MAPK8
SCHEMBL7140230 0.80 THRA (0.53) THRATHRBTTKMAPK8
SCHEMBL7130898 0.78 THRA (0.38) THRATHRBTTKMAPK8MEN1
SCHEMBL7130895 0.78 THRA (0.66) THRATHRB
SCHEMBL7137738 0.78 LRRK2 (0.38) THRATHRBTTKLRRK2ENPP3
SCHEMBL17253668 0.77 MAPT (0.47) TTKLRRK2MEN1MAPTTSHR
SCHEMBL23062638 0.77 TTK (0.37) THRATHRBTTKMAPK8JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608049-B2 Indazoles BAYER AKTIENGESELLSCHAFT (DE) 2003-08-19 US disclosed
EP-1324987-A1 INDAZOLES WITH THYROID HORMON LIKE ACTIVITY, A PROCESS FOR ITS PREPARATION AND ITS USE IN PHARMACEUTICAL COMPOSITIONS Bayer Aktiengesellschaft (DE) 2003-07-09 EP disclosed
US-20020193610-A1 Indazoles BAYER AKTIENGESELLSCHAFT (DE) 2002-12-19 US disclosed
WO-2002022586-A1 INDAZOLES HAVING AN ACTION SIMILAR TO THAT OF A THYROID HORMONE, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE IN MEDICAMENTS BAYER AKTIENGESELLSCHAFT (DE) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193610-A1 Indazoles CYP3A43, CYP3A5, CYP3A4 THRA 3910/4885THRB 4025/4885TTK 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.